Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUNLUN ENERGY
00135
5
CHINA OILFIELD
02883
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Inventory | 13.95%179.06M | -26.82%302.84M | -25.09%157.15M | 509.73%413.86M | 473.41%209.77M | --67.88M | --36.58M | ---- | ---- | ---- |
| Developing and for sale properties | ---- | ---- | ---- | -11.26%58.59M | -50.10%36.2M | -21.22%66.02M | -21.46%72.55M | -3.03%83.8M | 38.04%92.37M | --86.42M |
| Accounts receivable | 64.20%2.86B | 133.04%2.81B | 41.79%1.74B | -13.44%1.21B | 261.25%1.23B | 297.75%1.39B | 74.71%340.34M | 157.30%350.68M | 147.18%194.8M | 85.72%136.29M |
| Withholding and tax receivable | 0.74%50.22M | 10,137.79%57.43M | 7,762.78%49.85M | 0.00%561K | 13.01%634K | 0.00%561K | 0.00%561K | -17.50%561K | -34.99%561K | -21.21%680K |
| Cash and equivalents | 21.94%324.22M | -62.05%129M | 93.55%265.89M | -11.06%339.9M | -77.63%137.37M | 616.20%382.15M | 1,118.90%614M | 26.05%53.36M | -6.29%50.37M | -35.91%42.33M |
| Secured deposit | -1.02%816.43M | -36.42%402.3M | 103.59%824.86M | --632.78M | --405.16M | ---- | ---- | ---- | ---- | ---- |
| Financial assets at fair value-current assets | 186,100.00%5.59M | ---- | -62.50%3K | ---- | -98.99%8K | -91.32%796K | --796K | --9.17M | ---- | ---- |
| Derivative financial instruments-current assets | --188K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total current assets | 39.37%4.24B | 34.98%3.71B | 44.04%3.04B | 37.13%2.75B | 80.50%2.11B | 217.63%2B | 146.26%1.17B | 48.35%630.21M | 29.09%475M | 121.52%424.8M |
| Non-current assets | ||||||||||
| Property, plant and equipment | 11.37%1.45B | -4.13%1.31B | 58.60%1.31B | 463.32%1.36B | 898.84%823.59M | 1,042.97%242.01M | 209.74%82.46M | -32.87%21.17M | 27.54%26.62M | 218.37%31.54M |
| Investment property | ---- | ---- | ---- | 16.78%253.38M | -3.09%222.31M | -11.40%216.97M | -10.90%229.39M | 190.38%244.88M | 261.83%257.44M | 44.74%84.33M |
| Advance payment | 59.60%187.27M | 3,478.45%122.2M | -64.91%117.33M | 2.46%3.42M | 10,053.96%334.37M | 2.46%3.33M | 2.46%3.29M | 2.49%3.25M | 2.49%3.21M | 2.55%3.17M |
| Associated company interest | --82K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Intangible assets | 4.72%555K | -80.55%547K | -82.27%530K | -4.94%2.81M | -2.61%2.99M | -19.90%2.96M | -20.18%3.07M | -11.03%3.69M | -6.56%3.85M | 9.24%4.15M |
| Deferred tax assets | ---- | ---- | ---- | --12.24M | --32K | ---- | ---- | ---- | ---- | ---- |
| Total non-current assets | 74.98%2.51B | 41.95%2.32B | 3.65%1.44B | 249.84%1.64B | 331.01%1.38B | 68.92%467.68M | 8.13%321.33M | 104.27%276.86M | 164.09%297.19M | 79.38%135.54M |
| Total assets | 50.79%6.75B | 37.59%6.03B | 28.04%4.48B | 77.42%4.38B | 134.49%3.5B | 172.24%2.47B | 93.09%1.49B | 61.88%907.07M | 60.71%772.18M | 109.61%560.34M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Accounts payable | 93.17%1.69B | 43.98%1.83B | -9.81%872.8M | 60.39%1.27B | 204.14%967.74M | 50.54%792.07M | 14.04%318.19M | 146.90%526.14M | 59.16%279M | 272.10%213.1M |
| Tax payable | 7.29%23.22M | -71.22%14.81M | 5.25%21.65M | 646.39%51.45M | 95.90%20.57M | -33.20%6.89M | -28.17%10.5M | 257,875.00%10.32M | 1,028.65%14.62M | -98.67%4K |
| Amounts payable to associated parties-current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 54.71%84.27M |
| Bank loans and overdrafts | 1.99%1.7B | 5.85%1.42B | 100.30%1.67B | 991.95%1.34B | 66.72%833.15M | --122.8M | 532.19%499.73M | ---- | --79.05M | ---- |
| Derivative financial instrument-current liabilities | --1.96M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Financial lease liabilities-current liabilities | 15,473.66%185.64M | 12,560.72%197.89M | -25.55%1.19M | 0.32%1.56M | 16.01%1.6M | 9.80%1.56M | 13.96%1.38M | -9.62%1.42M | -31.39%1.21M | 245.81%1.57M |
| Total current liabilities | 54.61%4.04B | 29.35%3.51B | 38.48%2.62B | 188.52%2.72B | 110.86%1.89B | 68.38%941.27M | 128.01%895.53M | 40.12%559.02M | 29.07%392.76M | 247.88%398.97M |
| Net current assets | -54.20%195.13M | 558.01%192.32M | 91.07%426.04M | -97.24%29.23M | -18.67%222.98M | 1,389.68%1.06B | 233.39%274.18M | 175.59%71.19M | 29.21%82.24M | -66.49%25.83M |
| Total assets less current liabilities | 45.42%2.71B | 51.01%2.51B | 15.77%1.86B | 8.98%1.67B | 170.01%1.61B | 339.07%1.53B | 56.95%595.51M | 115.68%348.04M | 115.36%379.42M | 5.72%161.37M |
| Non-current liabilities | ||||||||||
| Long-term bank loan | -27.32%226.42M | -25.70%246.95M | 8.11%311.53M | 61.13%332.37M | --288.16M | 636.71%206.28M | ---- | --28M | --28M | ---- |
| Payments payable to related parties-non-current liabilities | ---- | ---- | ---- | ---- | ---- | -77.43%16.99M | 284.77%397.07M | --75.3M | --103.2M | ---- |
| Financial lease liabilities-non-current liabilities | 4,057.81%432.29M | 975,593.62%458.58M | 3,680.73%10.4M | -95.68%47K | -85.34%275K | -57.51%1.09M | -63.06%1.88M | -56.32%2.56M | -22.52%5.08M | 10,744.44%5.86M |
| Deferred tax liability | ---- | ---- | ---- | -22.46%5.43M | -6.75%7.19M | -31.68%7M | -30.27%7.71M | 34.00%10.24M | 74.07%11.05M | 201.30%7.64M |
| Special items of non-current liabilities | ---- | ---- | ---- | 62.11%1.1M | 62.11%1.1M | -26.77%681K | -22.96%681K | 10.45%930K | 7.80%884K | 3.31%842K |
| Total non-current liabilities | 104.61%658.71M | 108.15%705.53M | 8.49%321.93M | 46.07%338.95M | -27.16%296.72M | 98.26%232.04M | 174.84%407.33M | 716.03%117.04M | 980.00%148.21M | 321.08%14.34M |
| Total liabilities | 60.09%4.7B | 38.10%4.22B | 34.41%2.94B | 160.35%3.05B | 67.71%2.19B | 73.55%1.17B | 140.84%1.3B | 63.57%676.06M | 70.10%540.97M | 249.99%413.31M |
| Total assets less total liabilities | 33.04%2.05B | 36.41%1.81B | 17.42%1.54B | 2.34%1.33B | 596.82%1.31B | 461.06%1.3B | -18.62%188.17M | 57.12%231.01M | 42.32%231.21M | -1.48%147.03M |
| Total equity and non-current liabilities | 45.42%2.71B | 51.01%2.51B | 15.77%1.86B | 8.98%1.67B | 170.01%1.61B | 339.07%1.53B | 56.95%595.51M | 115.68%348.04M | 115.36%379.42M | 5.72%161.37M |
| Equity | ||||||||||
| Share capital | 0.00%2.64M | 0.00%2.64M | 0.00%2.64M | 0.00%2.64M | 0.00%2.64M | 0.00%2.64M | 0.00%2.64M | 0.00%2.64M | 0.00%2.64M | 0.00%2.64M |
| Reserve | 35.09%1.51B | 56.12%1.3B | 31.40%1.11B | 54.92%830.46M | 356.71%847.89M | 135.25%536.06M | -18.36%185.65M | 56.61%227.87M | 42.38%227.41M | -0.74%145.5M |
| Shareholders' Equity | 35.01%1.51B | 55.94%1.3B | 31.30%1.12B | 54.65%833.1M | 351.71%850.53M | 133.70%538.7M | -18.15%188.29M | 55.60%230.51M | 41.69%230.05M | -0.73%148.14M |
| Non-controlling interest | 27.83%540.62M | 3.41%510.13M | -8.20%422.92M | -34.87%493.3M | 387,247.06%460.71M | 150,477.53%757.41M | -110.21%-119K | 145.11%503K | 1,043.14%1.17M | ---1.12M |
| Total equity | 33.04%2.05B | 36.41%1.81B | 17.42%1.54B | 2.34%1.33B | 596.82%1.31B | 461.06%1.3B | -18.62%188.17M | 57.12%231.01M | 42.32%231.21M | -1.48%147.03M |
| Total equity and total liabilities | 50.79%6.75B | 37.59%6.03B | 28.04%4.48B | 77.42%4.38B | 134.49%3.5B | 172.24%2.47B | 93.09%1.49B | 61.88%907.07M | 60.71%772.18M | 109.61%560.34M |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | -- | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.